Treatment of detrusor-sphincter dyssynergia by pudendal nerve block in patients with spinal cord injury.
OBJECTIVE
To study the effects of pudendal nerve block with phenol on detrusor-sphincter dyssynergia in patients with spinal cord injury (SCI).


METHODS
Before-after trial performed by using a consecutive sample.


METHODS
Rehabilitation hospital affiliated with a medical school.


METHODS
Twenty-two male SCI patients (mean age, 46.3+/-11.9y; mean duration postinjury, 2.7y) with voiding dysfunction resulting from external urethral sphincter hypertonicity.


METHODS
Pudendal nerve block with 5% phenol solution under the guidance of electric stimulator.


METHODS
Outcomes were measured using (1) postvoid residual volume, maximal detrusor pressure, leak point pressure, bladder volume at the first uninhibited contraction, maximal bladder capacity, and urethral pressure profile; (2) rectoanal rest and squeeze pressures; and (3) quality of life measures for urination, quantified by the Quality of Life Index (QLI). Changes in bowel habit or autonomic dysreflexia were recorded.


RESULTS
The mean decrease in postvoid residual volume was 242.8mL (mean decrease, 66%) after treatment (P<.001). The mean reduction in leak point pressure and maximal detrusor pressure were 37.1cmH(2)O and 43.3cmH(2)O, respectively (P<.05). The mean QLI significantly improved from -.74+/-.38 to.42+/-.47 (P<.001). The rectoanal pressures showed no significant difference. No complaints of fecal incontinence or other complications were noted after treatment.


CONCLUSIONS
Pudendal nerve block performed by using 5% phenol solution was safe, easy to perform, and effective as a treatment for detrusor-sphincter dyssynergia in selected patients with SCI.
Tsai
Su-Ju
SJ
Department of Rehabilitation Medicine, Chung Shan Medical & Dental College, Taichung City, Taiwan. ru1219@seed.net.tw
Lew
Henry L
HL
Date
Elaine
E
Bih
Liu-Ing
LI
D000328:Adult; D001259:Ataxia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009122:Muscle Hypertonia / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D009130:Muscle, Smooth / Q000294:innervation* / Q000503:physiopathology*; D009407:Nerve Block; D011788:Quality of Life; D013119:Spinal Cord Injuries / Q000150:complications* / Q000503:physiopathology; D016896:Treatment Outcome; D014521:Urethra / Q000294:innervation* / Q000503:physiopathology*; D014554:Urination / Q000502:physiology; D014555:Urination Disorders / Q000209:etiology* / Q000503:physiopathology / Q000628:therapy*; D014563:Urodynamics / Q000502:physiology